Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Use of ciprofloxacin in cystic fibrosis patients.

Bosso JA.

Am J Med. 1989 Nov 30;87(5A):123S-127S.

PMID:
2589355
2.

Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.

Church DA, Kanga JF, Kuhn RJ, Rubio TT, Spohn WA, Stevens JC, Painter BG, Thurberg BE, Haverstock DC, Perroncel RY, Echols RM.

Pediatr Infect Dis J. 1997 Jan;16(1):97-105; discussion 123-6.

PMID:
9002118
3.

Efficacy of ciprofloxacin in patients with cystic fibrosis.

Bosso JA, Black PG.

Drug Intell Clin Pharm. 1988 Jul-Aug;22(7-8):551-3.

PMID:
3416737
4.
5.
6.

Ciprofloxacin monotherapy for acute pulmonary exacerbations of cystic fibrosis.

Goldfarb J, Stern RC, Reed MD, Yamashita TS, Myers CM, Blumer JL.

Am J Med. 1987 Apr 27;82(4A):174-9.

PMID:
3555032
7.

Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study.

Master V, Roberts GW, Coulthard KP, Baghurst PA, Martin A, Roberts ME, Onishko CR, Martin AJ, Linke RJ, Holmes M, Jarvinen A, Kennedy D, Colebatch KA, Hansman D, Parsons DW.

Pediatr Pulmonol. 2001 May;31(5):367-76.

PMID:
11340683
8.

Intravenous colistin sulphomethate in acute respiratory exacerbations in adult patients with cystic fibrosis.

Conway SP, Pond MN, Watson A, Etherington C, Robey HL, Goldman MH.

Thorax. 1997 Nov;52(11):987-93.

9.

Ciprofloxacin therapy in cystic fibrosis.

Scully BE, Nakatomi M, Ores C, Davidson S, Neu HC.

Am J Med. 1987 Apr 27;82(4A):196-201.

PMID:
3555036
10.
11.

Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.

Cantón R, Cobos N, de Gracia J, Baquero F, Honorato J, Gartner S, Alvarez A, Salcedo A, Oliver A, García-Quetglas E; Spanish Consensus Group for Antimicrobial Therapy in the Cystic Fibrosis Patient.

Clin Microbiol Infect. 2005 Sep;11(9):690-703. Review.

12.

Comparison of efficacy and tolerance of intravenously and orally administered ciprofloxacin in cystic fibrosis patients with acute exacerbations of lung infection.

Strandvik B, Hjelte L, Lindblad A, Ljungberg B, Malmborg AS, Nilsson-Ehle I.

Scand J Infect Dis Suppl. 1989;60:84-8.

PMID:
2756354
14.

Ciprofloxacin: comparative data in cystic fibrosis.

Rubio TT.

Am J Med. 1987 Apr 27;82(4A):185-8.

PMID:
3555034
15.

Clinical and pharmacokinetic aspects of ciprofloxacin in the treatment of acute exacerbations of pseudomonas infection in cystic fibrosis patients.

Steen HJ, Scott EM, Stevenson MI, Black AE, Redmond AO, Collier PS.

J Antimicrob Chemother. 1989 Nov;24(5):787-95.

PMID:
2599998
16.

Ciprofloxacin in the treatment of Pseudomonas infection in cystic fibrosis patients.

Rubio TT, Shapiro C.

J Antimicrob Chemother. 1986 Nov;18 Suppl D:147-52.

PMID:
3100490
18.

Ciprofloxacin as antipseudomonal treatment in patients with cystic fibrosis.

Schaad UB, Wedgwood J, Ruedeberg A, Kraemer R, Hampel B.

Pediatr Infect Dis J. 1997 Jan;16(1):106-11; discussion 123-6.

PMID:
9002119
19.

Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis.

McLaughlin FJ, Matthews WJ Jr, Strieder DJ, Sullivan B, Goldmann DA.

J Antimicrob Chemother. 1983 May;11 Suppl B:195-203.

PMID:
6352602
20.

A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study.

Chuchalin A, Csiszér E, Gyurkovics K, Bartnicka MT, Sands D, Kapranov N, Varoli G, Monici Preti PA, Mazurek H.

Paediatr Drugs. 2007;9 Suppl 1:21-31.

PMID:
17536872
Items per page

Supplemental Content

Write to the Help Desk